Bivariate shrinkage functions for wavelet-based denoising exploiting interscale dependency von Sendur, L., Selesnick, I.W.

Volltext

Bivariate shrinkage with local variance estimation von Sendur, L., Selesnick, I.W.

Volltext

Multiple hypothesis mapping of functional MRI data in orthogonal and complex wavelet domains von Sendur, L., Maxim, V., Whitcher, B., Bullmore, E.

Volltext

Fractional Gaussian noise, functional MRI and Alzheimer's disease von Maxim, Voichiţa, Şendur, Levent, Fadili, Jalal, Suckling, John, Gould, Rebecca, Howard, Rob, Bullmore, Ed

Volltext

Wavelets and functional magnetic resonance imaging of the human brain von Bullmore, Ed, Fadili, Jalal, Maxim, Voichita, Şendur, Levent, Whitcher, Brandon, Suckling, John, Brammer, Michael, Breakspear, Michael

Volltext

Subband adaptive image denoising via bivariate shrinkage von Sendur, L., Selesnick, I.W.

Volltext

Smooth wavelet frames with application to denoising von Selesnick, I.W., Sendur, L.

Volltext

Permutation testing of orthogonal factorial effects in a language-processing experiment using fMRI von Suckling, John, Davis, Matthew H., Ooi, Cinly, Wink, Alle Meije, Fadili, Jalal, Salvador, Raymond, Welchew, David, Şendur, Levent, Maxim, Vochita, Bullmore, Edward T.

Volltext

Implementation of an enhanced fixed point variable bit-rate MELP vocoder on TMS320C549 von Ertan, A.E., Aksu, E.B., Ilk, H.G., Karci, H., Karpat, O., Kolcak, T., Sendur, L., Demirekler, M., Cetin, A.E.

Volltext

Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOS... von Felip, E., Cho, B.C., Gutiérrez, V., Alip, A., Besse, B., Lu, S., Spira, A.I., Girard, N., Califano, R., Gadgeel, S.M., Yang, J.C.-H., Yamamoto, S., Azuma, K., Kim, Y.J., Lee, K.-H., Danchaivijitr, P., Ferreira, C.G., Cheng, Y., Sendur, M.A.N., Chang, G.-C., Wang, C.-C., Prabhash, K., Shinno, Y., Stroyakovskiy, D., Paz-Ares, L., Rodriguez-Cid, J.R., Martin, C., Campelo, M.R.G., Hayashi, H., Nguyen, D., Tomasini, P., Gottfried, M., Dooms, C., Passaro, A., Schuler, M., Gelatti, A.C.Z., Owen, S., Perdrizet, K., Ou, S.-H.I., Curtin, J.C., Zhang, J., Gormley, M., Sun, T., Panchal, A., Ennis, M., Fennema, E., Daksh, M., Sethi, S., Bauml, J.M., Lee, S.-H.

Volltext

Translation and validation of the Turkish version of the Ankylosing Spondylitis Quality of Life (ASQOL) questionnaire von Duruöz, M. T., Doward, L., Turan, Y., Cerrahoglu, L., Yurtkuran, M., Calis, M., Tas, N., Ozgocmen, S., Yoleri, O., Durmaz, B., Oncel, S., Tuncer, T., Sendur, O., Birtane, M., Tuzun, F., Bingol, U., Kirnap, M., Celik Erturk, G., Ardicoglu, O., Memis, A., Atamaz, F., Kizil, R., Kacar, C., Gurer, G., Uzunca, K., Sari, H.

Volltext

EP.12H.02 Amivantamab, An EGFR-MET Bispecific Antibody, with Cetrelimab, An Anti-PD-1 Antibody, In Advanced NSCLC: Phase 1/2 Polydamas von Voon, P.J., Tan, J.-L., Spira, A.I., Keam, B., Lee, S.-H., Xia, B., Artis, E., Dobbs, J., Baudelet, C., Baig, M., Bauml, J.M., Sendur, M.A., Cho, B.C.

Volltext

1271P Integrating machine learning prediction and causal inference analysis to unravel determinants of progression in EGFR-mutant, advanced NSCLC von Bozcuk, H., Sert, L., Kaplan, M.A., Tatli, A.M., Karaca, M., Kilictas, B., Artac, M., Sendur, M.A.N., Bilgin, B., Balli, S., Demirkazik, A., Kilickap, S., Taban, H., Güzel, H.G., Kocer, M., Koylu, B., Biricik, F.S., Karakaya, G., Coskun, H.S., Alemdar, M.S.

Volltext

436TiP DYNASTY-Breast02: A phase III trial of BNT323/DB-1303 vs investigator's choice chemotherapy in HER2-low, hormone receptor positive, metastatic breast cancer von O'Shaughnessy, J., Cortés, J., Schmid, P., Xu, B., Shao, Z., Teixeira, L., Sendur, M.A.N., Sabanathan, D., Kim, S-B., Colleoni, M.A., Wenger, M., Lee, J.H., Gu, V., Qiu, Y., Liu, S., Fang, H., Shi, R., Zhu, Z., Hamilton, E.P.

Volltext

663P Safety and preliminary efficacy of the KRAS G12C Inhibitor MK-1084 in solid tumors and in combination with pembrolizumab in NSCLC von Rojas, C., Lugowska, I., Juergens, R., Sacher, A., Weindler, S., Sendur, M.A.N., Dziadziuszko, R., Pal, A., Castanon Alvarez, E., Ahern, E.S., Lakhani, N., Chen, L-C., Jemielita, T., Choi, Y.S., Stathis, A.

Volltext

714MO Datopotamab deruxtecan (Dato-DXd) in patients with endometrial (EC) or ovarian cancer (OC): Results from the phase II TROPION-PanTumor03 study von Oaknin, A., Ang, J.E., Rha, S.Y., Yonemori, K., Kristeleit, R., Lin, C-C., Satoh, T., Garcia, P. Estevez, Sendur, M.A.N., Rodríguez, L. Medina, Italiano, A., Lugowska, I., Ray-Coquard, I.L., Oza, A.M., Zhao, J.L., Gajavelli, S., Filant, J., Bodla, S., Janjigian, Y.Y., Meric-Bernstam, F.

Volltext

The effect of primary surgery in patients with stage IV breast cancer with bone metastasis only (protocol bomet MF14-01); a multi-center, registry study von Soran, A., Dogan, L., Ozbas, S., Isık, A., Trablus, D., Demirci, U., Karanlık, H., Soyder, A., Dag, A., Bilici, A., Dogan, M., Koksal, H., Sendur, M.A.N., Gulcelik, M.A., Maralcan, G., Cabioglu, N., Yeniay, L., Utkan, Z., Simsek, T., Karadurmus, N., Daglar, G., Yıldız, B., Uras, C., Tukenmez, M., Yildirim, A.O., Kutun, S., Ozaslan, C., Karaman, N., Akcay, M.N., Toktas, O., Sezgin, E.

Volltext

PACIFIC-5: Phase III study of durvalumab after either concurrent or sequential chemoradiotherapy (CRT) in patients with stage III NSCLC von Wu, Y.-L., Wang, L., Sendur, M.A.N., Kim, Y.-C., Zhu, Z., Cheng, Y., Li, P., Qin, Y., Macpherson, E., Dennis, P.A., Lu, S.

Volltext

Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOS... von Felip, E, Cho, B.C, Gutierrez, V, Alip, A, Besse, B, Lu, S, Spira, A.I, Girard, N, Califano, R, Gadgeel, S.M, Yang, J.C.-H, Yamamoto, S, Azuma, K, Kim, Y.J, Lee, K.-H, Danchaivijitr, P, Ferreira, C.G, Cheng, Y, Sendur, M.A.N, Chang, G.-C, Wang, C.-C, Prabhash, K, Shinno, Y, Stroyakovskiy, D, Paz-Ares, L, Rodriguez-Cid, J.R, Martin, C, Campelo, M.R.G, Hayashi, H, Nguyen, D, Tomasini, P, Gottfried, M, Dooms, C, Passaro, A, Schuler, M, Gelatti, A.C.Z, Owen, S, Perdrizet, K, Ou, S.-H.I, Curtin, J.C, Zhang, J, Gormley, M, Sun, T, Panchal, A, Ennis, M, Fennema, E, Bauml, J.M, Daksh, M, Sethi, S, Lee, S.-H

Volltext

124P Talazoparib in locally advanced or metastatic breast cancer patients: Experience from an early access program in Turkey von Sendur, M.A.N., Cakar, B., Hızal, M., Eraslan, E., Aksoy, S., Paydas, S., Demir, N., Sen, F., Bulut, G., Oruc, K., Oyan Uluc, B., Ozdemir, N., Sakin, A., Erdem, D., Ozkan, M., Disel, U., Ekinci, F., Okten, I.N., Ozer, L., Gokmen, E.

Volltext